Altering the community of gut bacteria promotes health and increases lifespan

Study published in Cell provides first systemic understanding of aging gut

2014-01-16

(Press-News.org) Contact information: Kris Rebillot
krebillot@buckinstitute.org
415-209-2080
Buck Institute for Age Research
Altering the community of gut bacteria promotes health and increases lifespan Study published in Cell provides first systemic understanding of aging gut Scientists at the Buck Institute for Research on Aging have promoted health and increased lifespan in Drosophila by altering the symbiotic, or commensal, relationship between bacteria and the absorptive cells lining the intestine. The research, appearing in the January 16, 2014 edition of Cell, provides a model for studying many of the dysfunctions that are characteristic of the aging gut and gives credence to the growing supposition that having the right balance of gut bacteria may be key to enjoying a long healthy life.

Even though recent research in humans has linked the composition of gut flora with diet and health in the elderly and the list of age-related diseases associated with changes in gut bacteria include cancer, diabetes, and inflammatory bowel disease, lead author and Buck faculty Heinrich Jasper, PhD, says there is no systematic understanding of how we go from having a young, healthy gut to one that is old and decrepit. "Our study explores age-related changes in the gut that include increased oxidative stress, inflammation, impaired efficiency of the immune response, and the over-proliferation of stem cells," said Jasper. "It puts these changes into a hierarchical, causal relationship and highlights the points where we can intervene to rescue the negative results of microbial imbalance."

Jasper says the bacterial load in fly intestines increases dramatically with age, resulting in an inflammatory condition. The imbalance is driven by chronic activation of the stress response gene FOXO (something that happens with age), which suppresses the activity of a class of molecules (PGRP-SCs, homologues of PGLYRPs in humans) that regulate the immune response to bacteria. PGRP-SC suppression deregulates signaling molecules (Rel/NFkB) that are important to mount an effective immune response to gut bacteria. The resulting immune imbalance allows bacterial numbers to expand, triggering an inflammatory response that includes the production of free radicals. Free radicals, in turn, cause over-proliferation of stem cells in the gut, resulting in epithelial dysplasia, a pre-cancerous state.

Jasper said the most exciting result of their study occurred when his group increased the expression of PGRP-SC in epithelial cells of the gut, which restored the microbial balance and limited stem cell proliferation. This enhancement of PGRP-SC function, which could be mimicked by drugs, was sufficient to increase lifespan of flies. "If we can understand how aging affects our commensal population – first in the fly and then in humans - – our data suggest that we should be able to impact health span and life span quite strongly, because it is the management of the commensal population that is critical to the health of the organism."

### Other Buck Institute researchers contributing to the study include Linlin Guo and Jason Karpac, as well as Susan L. Tran, from the Department of Biology, University of Rochester, Rochester, NY. The work was supported by the National Institute on Aging (NIH RO1 AG02812), the Ellison Medical Foundation (AG-SS-224-08), and by the American Federation for Aging Research.

Citation: "PGRP-SC2 Promotes Gut Immune Homeostasis to Limit Commensal Dysbiosis and Extend Lifespan" ; publishing January 12, 2014 in Cell

About the Buck Institute for Research on Aging The Buck Institute is the U.S.'s first independent research organization devoted to Geroscience – focused on the connection between normal aging and chronic disease. Based in Novato, CA, The Buck is dedicated to extending "Healthspan", the healthy years of human life and does so utilizing a unique interdisciplinary approach involving laboratories studying the mechanisms of aging and those focused on specific diseases. Buck scientists strive to discover new ways of detecting, preventing and treating age-related diseases such as Alzheimer's and Parkinson's, cancer, cardiovascular disease, macular degeneration, osteoporosis, diabetes and stroke. In their collaborative research, they are supported by the most recent developments in genomics, proteomics, bioinformatics and stem cell technologies. For more information: http://www.thebuck.org

ELSE PRESS RELEASES FROM THIS DATE:

Drugs that weaken traumatic memories hold promise for PTSD treatment

2014-01-16

Drugs that weaken traumatic memories hold promise for PTSD treatment Memories of traumatic events often last a lifetime because they are so difficult to treat through behavioral approaches. A preclinical study in mice published by Cell Press January 16th in the journal Cell ...

The life cycle of a jellyfish (and a way to control it)

2014-01-16

The life cycle of a jellyfish (and a way to control it) Those free-swimming jellyfish in the sea don't start out in that familiar medusa form, but rather start as sessile and asexual polyps. Now, researchers reporting in the Cell Press journal Current Biology on January ...

JCI early table of contents for Jan. 16, 2014

2014-01-16

JCI early table of contents for Jan. 16, 2014 Macrophages target tumor cells following monoclonal antibody therapy Monoclonal antibodies directed against tumor antigens have proven effective for treating some forms of cancer. Despite the increasing use ...

Macrophages target tumor cells following monoclonal antibody therapy

2014-01-16

Macrophages target tumor cells following monoclonal antibody therapy Monoclonal antibodies directed against tumor antigens have proven effective for treating some forms of cancer. Despite the increasing use of monoclonal antibody therapy, it is not clear ...

Targeting a cell cycle inhibitor promotes beta cell replication

2014-01-16

Targeting a cell cycle inhibitor promotes beta cell replication One of the factors underlying the development of type 2 diabetes is loss of β cell mass, resulting in decreased insulin production. Once lost, β cell mass cannot be restored. In ...

Unraveling misfolded molecules using 'reprogrammed' yeast protein

2014-01-16

Unraveling misfolded molecules using 'reprogrammed' yeast protein Implications for new brain disease therapies PHILADELPHIA - At the heart of brain diseases such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease, and Parkinson's ...

The symphony of life, revealed

2014-01-16

The symphony of life, revealed A new imaging technique captures the vibrations of proteins, tiny motions critical to human life BUFFALO, N.Y. — Like the strings on a violin or the pipes of an organ, the proteins in the human body vibrate in different patterns, scientists ...

How metabolism and brain activity are linked

2014-01-16

How metabolism and brain activity are linked Study sheds light on why diet may help control seizures in epilepsy patients A new study by scientists at McGill University and the University of Zurich shows a direct link between metabolism in brain cells and ...

Study identifies drug that could improve treatment of PTSD

2014-01-16

Study identifies drug that could improve treatment of PTSD New study identifies drug that could improve treatment of post-traumatic stress disorder CAMBRIDGE, Mass-- Nearly 8 million Americans suffer from posttraumatic stress disorder (PTSD), a condition ...

Preventing cell death from infection: Scientists demonstrate method to find new therapies

2014-01-16

Preventing cell death from infection: Scientists demonstrate method to find new therapies LA JOLLA, CA—January 16, 2014—Scientists at The Scripps Research Institute (TSRI) have demonstrated the power of a new drug discovery technique, which allows them to find—relatively ...

LAST 30 PRESS RELEASES:

How rice plants tell head from toe during early growth

Scientists design solar-responsive biochar that accelerates environmental cleanup

Construction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases

Deep learning-based discovery of tetrahydrocarbazoles as broad-spectrum antitumor agents and click-activated strategy for targeted cancer therapy

DHL-11, a novel prieurianin-type limonoid isolated from Munronia henryi, targeting IMPDH2 to inhibit triple-negative breast cancer

Discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model

Neg-entropy is the true drug target for chronic diseases

Oxygen-boosted dual-section microneedle patch for enhanced drug penetration and improved photodynamic and anti-inflammatory therapy in psoriasis

Around the world, children’s cooperative behaviors and norms converge toward community-specific norms in middle childhood, Boston College researchers report